Schizoaffective Disorders Completed Phase 2 Trials for Betahistine (DB06698)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00709202Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight GainTreatment